Ablaze Pharmaceuticals
Manufacturing · China · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Wehai Rd Fl 3 Rm 122 No 696, Shanghai, S...Website
www.ablazepharma.comRevenue
<$5 MillionIndustry
About Ablaze Pharmaceuticals
Ablaze Pharmaceuticals Org Chart
Is Ablaze Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Ablaze Pharmaceuticals is spiking on competitors!
Click to see if Ablaze Pharmaceuticals had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Ablaze Pharmaceuticals
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Ablaze Pharmaceuticals has new funding data
Check if Ablaze Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Ablaze Pharmaceuticals recently announced quarterly report
Product Launch: Get notified when Ablaze Pharmaceuticals launches new products
Ablaze Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Ablaze Pharmaceuticals
Find more new buyers
Company Profile Activity
Activity Insights
Ablaze Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Ablaze Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Ablaze Pharmaceuticals.
Ablaze Pharmaceuticals Tech Stack
A closer look at the technologies used by Ablaze Pharmaceuticals
Ablaze Pharmaceuticals News & Media
Ablaze Pharmaceuticals and Yonghe Pharma Initiate Development and Manufacturing Services Agreement for Targeted Radiopharmaceutical Therapies
SHANGHAI, Dec. 26, 2022 /PRNewswire/ -- Ablaze Pharmaceuticals ("Ablaze") announced the initiation of a development and manufacturing services agreement with Yonghe Pharmaceutical Technology Co., Ltd. ("Yonghe") to develop series of targeted radiopharmaceutical therapy ("TRT") products....Ablaze Pharma Aligned The Strategic Agreement With Wenjiang District Government of Chengdu to Build-up the Innovative R&D and Manufacturing Center for Targeted Radiopharmaceutical Therapies
SHANGHAI, Aug. 2, 2022 /PRNewswire/ -- In July 2022, Ablaze Pharma and Wenjiang District Government of Chengdu jointly signed the strategic agreement during the Conference of Major Advanced Manufacturing Projects by Foreign Direct Investment. About 26,000㎡ of industrial land is selected...Ablaze Pharmaceuticals Raises $75M in Series A Financing
Ablaze Pharmaceuticals, a Shangai, China and San Diego, CA-based clinical-stage pharmaceutical company focused on the development and commercialization of innovative targeted radiopharmaceutical therapies (TRT) against tumor targets, raised $75m in Series A financing round. The round was co-led by Vivo Capital and AdvanTech Capital with participation from RAYZ Investments, Nan Fung Life Sciences, Pivotal bioVenture Partners […] The post Ablaze Pharmaceuticals Raises $75M in Series A Financing ap
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ablaze Pharmaceuticals
Ablaze Pharmaceuticals is a clinical-stage bio-pharmaceutical company with a focus on targeted radiotherapy in cancer patients. The company has headquarters in Shanghai, China.... Read More